Synthesis and Antischistosomal Activity Profile of Several Sub-Series of Redox-Active Lead 3‑BenzylmenadionesInvestigations of the Modes of Action in Yeast
4 affiliations
- 1Laboratoire d’Innovation Moléculaire et Applications (LIMA), Team Bio(IN)organic and Medicinal Chemistry , UMR7042 CNRS-Université de Strasbourg-Université Haute-Alsace, European School of Chemistry, Polymers and Materials (ECPM) , 25, rue Becquerel , ,
- 2Université Paris-Saclay , CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC) , ,
- 3, Kreuzstrasse 2 , ,
- 4Department of Microbial Pathogens and Immunity , Rush University Medical Center , 1735 West Harrison Street , , ,
Abstract
Three sub-series of 3-benzylmenadiones were discovered as new antischistosomal agents. The most potent representatives, called schistodiones, exhibited IC50 values <5 μM against larvae and ex vivoSchistosoma mansoni adult worms and moderate activity per os in the S. mansoni-infected mouse model in vivo. We synthesized the putative 3-benzoylmenadione metabolites of the most active compounds and explored the possible mode(s) of action using the yeast model and the recombinant drug target S. mansoni thioredoxin-glutathione reductase. Two drug targets were identified in yeast: the yeast NADH dehydrogenase and Cox15, involved in events responsible for respiratory growth defect in yeast, respectively: (i) the bioreductive activation step producing reactive oxygen species and (ii) the heme a synthase inhibition. These two drug targets are discussed in the context of S.mansoni biology, with S. mansoni thioredoxin–glutathione reductase redox-cycling and a potential source of oxidative stress in the parasite.
Related
- Frequency and Laminar Profile of Feature Specific Visual Activity Revealed by Interleaved EEG-fMRI
- Exploring the Chemical Profile and Biological Activities of Eryngium dichotomum: UHPLC–MS/NMR Characterization, and In Vitro Antioxidant Activity Along with the Antitumor Effect of Falcarinol
- Improving the Polyphenol Profile, Antioxidant and Antiglycation Activity of Onion Outer Scales with Chamomile Treatment.
- The association between honey consumption amount and physical activity, sleep quality, and Nottingham health profile in young adults.
- Design, Synthesis, and Structure–Activity Relationship Studies of Spirotryprostatin A-Inspired Spirooxindole-Diketopiperazine Derivatives with Antifungal Activity
BibTeX
@article{pecourneau2026synthesis,
title = {{Synthesis and Antischistosomal Activity Profile of Several Sub-Series of Redox-Active Lead 3‑BenzylmenadionesInvestigations of the Modes of Action in Yeast}},
author = {Jeremy Pecourneau and Jimmy Richard and Brigitte Meunier and Maude Dagenais and Cécile Häberli and David L. Williams and Jennifer Keiser and Elisabeth Davioud-Charvet},
journal = {ACS omega},
year = {2026},
month = sep,
doi = {10.1021/acsomega.6c06911},
url = {https://europepmc.org/article/PMC/PMC13670326},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Synthesis and Antischistosomal Activity Profile of Several Sub-Series of Redox-Active Lead 3‑BenzylmenadionesInvestigations of the Modes of Action in Yeast
AU - Jeremy Pecourneau
AU - Jimmy Richard
AU - Brigitte Meunier
AU - Maude Dagenais
AU - Cécile Häberli
AU - David L. Williams
AU - Jennifer Keiser
AU - Elisabeth Davioud-Charvet
PY - 2026
DA - 2026/09/29
JO - ACS omega
DO - 10.1021/acsomega.6c06911
UR - https://europepmc.org/article/PMC/PMC13670326
AB - Three sub-series of 3-benzylmenadiones were discovered as new antischistosomal agents. The most potent representatives, called schistodiones, exhibited IC50 values <5 μM against larvae and ex vivoSchistosoma mansoni adult worms and moderate activity per os in the S. mansoni-infected mouse model in vivo. We synthesized the putative 3-benzoylmenadione metabolites of the most active compounds and explored the possible mode(s) of action using the yeast model and the recombinant drug target S. mansoni thioredoxin-glutathione reductase. Two drug targets were identified in yeast: the yeast NADH dehydrogenase and Cox15, involved in events responsible for respiratory growth defect in yeast, respectively: (i) the bioreductive activation step producing reactive oxygen species and (ii) the heme a synthase inhibition. These two drug targets are discussed in the context of S.mansoni biology, with S. mansoni thioredoxin–glutathione reductase redox-cycling and a potential source of oxidative stress in the parasite.
SN - 2470-1343
ER -